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Abstract
Background: Aminoglycoside antibiotics are widely used in medical centers, particularly to treat infections. 
The resistance developed against these agents is a huge concern in health care. A number of researchers have 
reported that hospital and municipal wastewaters are among the most important dissemination sources of 
these agent into the environment. Some, however, do not agree with this opinion. In the present study, the 
prevalence of aminoglycoside resistance genes was investigated in raw and effluent wastewater from hospital 
and municipal wastewater treatment plants.
Methods: To conduct this descriptive-analytical study, 30 samples were taken according to sampling principles 
and cold cycle and transferred to the molecular laboratory. DNA was extracted by the freeze-thaw method using 
a kit (Promega). The genes aac(3)-IIa and aac(6’)-Ib which code aminoglycoside resistance were examined in 
this study.
Results: The results indicated that the studied genes are present in 35% of urban and hospital wastewaters, and 
their frequency percentage is higher in hospital wastewater (52%) than urban wastewater (48%). The studied 
genes were identified in 61% of raw hospital wastewater samples; however, they were not detected in the output 
wastewater from the studied treatment plants.
Conclusion: Although, the studied genes were not detected in the final effluent, there is a high potential for 
their release into the environment. The current study demonstrated that the coding genes of aminoglycoside 
antibiotic resistance are present in raw urban and hospital wastewaters. In the case of improper exploitation of 
wastewater treatment plants, the output water can contaminate other environmental sections, such as soil and 
water resources, and result in the emission of these contaminants. 
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Introduction
Excessive use of antibiotics in the treatment of humans 
and animals leads to antibiotic resistance (1-3). Antibi-
otic resistant bacteria (ARB) and antibiotic resistant genes 
(ARGs) cause serious problems in the treatment of infec-
tious diseases. They enter the environment in different 
ways. Urban and hospital wastewaters have a high poten-
tial for the release of resistant bacteria and genes into the 
environment (4,5). Such release increases concerns about 
public health (4). Antibiotic resistance in the environment 
can be transferred to nonpathogenic bacteria from patho-
genic bacteria and increase pressure on the aquatic ecolo-
gy through physiological changes and population mobility 
(4-6). Research has shown that a large number of ARB and 
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ARGs, in particular hospital strains, have been found in 
regions where hospital wastewaters have been discharged 
(7). Importantly, some of these contaminated water re-
sources are used for public water supplies. Some inves-
tigations have revealed that discharge of hospital waste-
water is associated with the widespread dissemination of 
resistant bacteria in the environment (1). Other studies 
have demonstrated that urban wastewaters are important 
means through which resistant bacteria and genes are dis-
charged into the environment (8). Some researchers have 
shown that resistant bacteria and genes are rarely removed 
from wastewater in treatment plant facilities (3,4). Some 
studies have even indicated that the number of resistant 
bacteria increases in such facilities (9). 
Aminoglycosides are a group of medications that have 
similar chemical, antimicrobial, pharmacological, and 
toxic properties. Currently, this group includes strepto-
mycin, gentamicin, tobramycin, kanamycin, amikacin, 
netilmicin, neomycin, sizomycin, and others (10). Ami-
noglycoside antibiotics are widely used in medical centers 
to treat life-threatening infections caused by gram-neg-
ative bacteria (10,11). Resistance to aminoglycosides is 
often caused by drug enzymatic changes by phosphoryla-
tion, adenylation, and acetylation of amine and hydroxyl 
groups, the most common mechanism of antibiotic resis-
tance in bacteria (12). Among enzymes that change ami-
noglycosides, the aac(6’)-Ib is predominant and causes re-
sistance to many antibiotics. This gene was first identified 
in 1986 in Klebsiella pneumoniae isolates (13). Although 
the production of aminoglycoside-changing enzymes is 
the most common mechanism for producing resistance to 
aminoglycosides, the gram-negative bacteria that produce 
16S rRNA methylase have become increasingly preva-
lent in recent years (14), and such widespread resistance 
to aminoglycosides has become a huge challenge to the 
medical profession (15). Filipova et al (16) and Chan-
drakanth et al (17) reported aminoglycoside resistant bac-
teria isolated from clinical environments. The aac gene 
is distributed in different microorganisms isolated from 
polluted waters (18-20). Szczepanowski et al (21) reported 
that aminoglycoside resistance genes prevailed in clini-
cal compartments and can be spread to the environment 
through hospital wastewater. Considering the risk of these 
pollutant genes entering the environment, this study ex-
amined the prevalence of the aac(3)-IIa and aac(6’)-Ib 
resistant genes in raw and wastewater effluent and deter-
mined the role of urban wastewater treatment plants in 
removing/reducing aac genes. 
Methods
Preparation of samples 
A certain volume of the main samples (50 ml) was taken 
and centrifuged for 10 minutes at 6000 rpm. The sediment 
was extracted, 300 μl of distilled water was added, and the 
solution was subjected to freeze and thaw using liquid ni-
trogen and boiling water, each for 1 minute periodically at 
4-5 stages (22). 
DNA extraction
DNA was extracted using a Promega Wizard Genomic 
DNA purification kit, (Madison, WI) in 3 stages. In the 
lysing stage of the cell, pipetting was performed well af-
ter the addition of cell lyse solution (600 μl). The solution 
was then incubated at 80°C for 5 minutes. Finally, RNase 
was added, and the solution was incubated again for 15-60 
minutes at 37°C. At the protein precipitation stage, 200 μl 
of precipitation solution was added and incubated for 5 
minutes on ice, followed by centrifugation at 13000-16000 
rpm for 3 minutes. At the DNA precipitation stage, the 
top liquid was transferred to a tube containing 600 μl of 
isopropanol at room temperature and mixed. Afterwards, 
600 μl of 70% ethanol was added at room temperature and 
the mixture was centrifuged for 2 minuts at 13 000-16 000 
rpm. The ethanol was then removed and the tubes dried 
under ambient conditions. DNA was suspended in 100 μl 
of distilled water and kept for 1 night at 4°C; it was ulti-
mately maintained at -20°C until molecular experiments 
were performed. The concentration of the extracted DNA 
was read by spectrophotometry (Nanodrop ND 1000). 
PCR method
The pair of primers used to amplify the aac(3)-IIa and 
aac(6’)-Ib genes are listed in Table 1. PCR amplification 
was conducted at a volume of 25 λ containing 2.5 μl buffer 
10X PCR, 1 μl of each primer, 0.75 μl of MgCl2, 0.5 μl of 
dNTP, 0.35 μl of tag polymerase, 2 μl of the DNA template, 
and 14.9 μl of deionized water. All PCR experiments had 
positive and negative controls. The process was performed 
using the initial denaturation stage for 5 minutes at 94°C, 
35 cycles at 94°C for 45 seconds (denaturation), at 53°C 
for 30 seconds (annealing), and at 72°C for 1 minute (ex-
tension). The final extension was performed at 72°C for 
10 minute. PCR products were investigated using electro-
phoresis (1.5%) and DNA safe stain. They were then de-
Table 1. Characteristics of primers
Primers Target gene Sequence (5'-3') Amplified  size (bp) Annealing temperature (˚C) References
F
R Aac(3)-IIa
F: 5-CGGAAGGCAATAACGGAG- 3
R: 5 -TCGAACAGGTAGCACTGAG -3 749 bp 53°C (23)
F
R Aac(6’)-Ib
F: 5′-ATG ACT GAG CAT GAC CTT G-3′
R: 5′-AAGGGTTAGGCAACACTG-3′
524 bp 53°C (23)
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tected on Transluminar UV. 
Data analysis
To compare the presence and absence of genes among var-
ious sites, the chi-square test was employed. McNemar test 
was utilized before and after each treatment plant.
Results
Amplified multiplex genes are illustrated in Figure 1. The 
results indicated that aac(3)-IIa and aac(6’)-Ibgenes were 
found in 35% of the samples (Figure 2A). The aac(3)-IIa 
(37%) was found in a larger number of samples than the 
aac(6’)-Ib gene (33%) (Figure 2B). Distinctive analysis of 
urban and hospital wastewaters indicated that the detec-
tion percentage of the studied genes was higher in hos-
pital wastewaters (52%) than in urban wastewaters (48%) 
(Figure 2C).
The results revealed that the aac(3)-IIa gene was present 
in 50% of the hospital wastewater samples, while aac(6’)-
Ib was observed in 42% of the samples. The studied genes 
were found in 28% of the urban wastewater samples. In-
vestigations of the input and output of urban wastewaters 
indicated that, generally, 56% of the studied genes were 
found in the input. aac(3)-IIa and aac(6’)-Ib were pre-
sented in the raw samples 56% and 44%, respectively. The 
studied genes were found in none of the effluent of urban 
wastewater treatment plants, but in 61% of the wastewater 
samples from hospitals. One of the studied hospitals had 
its own wastewater treatment plant; the results demon-
strated that 83% of samples from this plant’s raw waste-
water contained the studied genes, but none of the genes 
were found in the effluent.
Discussion
Aminoglycoside antibiotics are widely used in medical 
clinics, especially to treat life-threating infections caused 
by gram-negative bacteria (24-26). Because of the wide-
spread incidence of aminoglycoside resistance and the 
resulting complications for the medical field (24), the 
present study investigated two aminoglycoside-resistance 
genes. Clinical genes resistant to aminoglycosides were 
found to be present in municipal wastewaters. In their 
studies, Guardabassi et al (27), Heuer et al (18), and Aali et 
al (8) also indicated that the genes resistant to aminoglyco-
sides exist in environmental resources. The results of this 
study revealed the lowest percentage of clinically genes. 
The results of other studies also confirm these findings. 
Jakobsen et al (28) found aac genes in wastewater isolates 
and showed a possible dissemination of aac from hospital 
to wastewater. Aali et al (8) reported an association be-
tween the lowest number of bacteria and aminoglycoside-
resistance genes. The reason can be attributed to less use 
of aminoglycoside antibiotics. Recently, the consumption 
of some members of the aminoglycoside family (such as 
Figure 1. Aminoglycoside resistance genes, aac(3)-IIa (749) bp  
and aac(6’)-Ib(524 bp).
Figure 2. (A) Overall detection of ARGs, (B) total detection of aac(3)-Iia and aac(6’)-Ib, and (C) differences between municipal and hospital 
wastewaters. 
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gentamycin) has been limited because of side effects; how-
ever, studies have indicated that resistance can develop 
even in low antibiotic concentrations (29). Heuer et al (18) 
attributed the diversity of the genes that code resistance to 
gentamycin (including Aac3-I) in different environments 
to the increased frequency of genetic transfer elements. 
The primary mechanism involved in resistance to genta-
mycin has been reported as enzyme deactivation, and over 
50 types of enzyme have been identified. These enzymes, 
based on their biochemical action, include acetyltransfer-
ases, phosphotransferases, and nucleotidyl transferases 
(adenylyl tranferases) (16,17,30). These enzymes are cod-
ed by various genes, including Aac, Aph, and Ant (Aad). 
The mentioned enzymes and the coder genes have been 
identified in a wide range of isolated bacteria (Aeromonas, 
Escherichia, Vibrio, Salmonella, and Listeria) from hospital 
environments and contaminated waters (18-20). The Aac3 
gene has been identified as the coder of aminoglycoside-
N-acetyl transferases in the microbial populations isolated 
from wastewater treatment facilities, river water, and ag-
ricultural regions (31,32). This can also be applicable to 
this study, yet complementary research is necessary to in-
vestigate the role of key factors in genetic transfer in the 
studied wastewaters. 
The findings of the current study revealed that the per-
centages of aac(3)-IIa and aac(6’)-Ib genes are higher in 
hospital wastewaters than in urban wastewaters. These 
results are consistent with those of other researchers. The 
high rate of aminoglycoside-resistance genes in hospitals 
can be caused by common unnecessary prescriptions for 
patients. This also demonstrates the aminoglycoside resis-
tant mobile genetic agents’ movements between clinical 
and environmental bacteria (18). Plasmid and integrons 
have main roles in the dissemination of these agents (30). 
In their study of the Aac3-1 gene, Aali et al (8) reported 
that the genes and bacteria resistant to aminoglycosides 
are more prevalent in hospital than urban wastewaters. 
Their low percentage in urban wastewaters can be related 
to process design and operation. The aac(3)-IIagene was 
identified in hospital wastewaters more than the aac(6’)-Ib 
gene. This can be due to bacteria carrying or better ex-
pression of the aac(3)-IIa gene. 
In the current study, contrary to other studies, neither 
aac(3)-IIa nor aac(6’)-Ib genes were detected in effluent 
wastewater samples from different wastewater treatment 
plants. Szczepanowski et al (21) identified many ami-
noglycoside resistance genes (eg, aacA, aacA1, aacA4, 
aacA7, aacA29b, aacC1, aacC2, aacC3, aacC4, aac(3)-Id, 
and aac[69]-Im) in the final effluent of wastewater treat-
ment plants. The absence of the studied resistance genes 
in the effluent wastewater can be due to the effect of the 
plant’s disinfection unit, the shock caused by a huge or-
ganic load, or the specific conditions of the wastewater 
treatment plants. 
Conclusion
Human contact with resistant bacteria and genes has been 
a health concern associated with the management of dis-
eases. This contact can occur through various means such 
as environmental resources. Hospital and urban wastewa-
ter plays a great role in the spread of resistant genes and 
bacteria. Wastewater treatment plants are very important 
as a controlling barrier against these contaminants enter-
ing environmental resources. Therefore, the design, op-
eration, and continual monitoring of the effluent from 
treatment plants together with the monitoring of design 
parameters can be essential in the success of wastewater 
treatment plants in controlling these pollutants. Various 
parameters of treatment together with gene expression 
and the way genes are affected in the wastewater treatment 
process require further broad and extensive research. The 
presence of aac(3)-IIa and aac(6’)-Ib genes in the waste-
water samples of treatment plants indicates that conven-
tional treatment approaches cannot guarantee the absence 
of these genes; thus it is suggested that more advanced 
methods be applied to control antibiotic-resistant genes.
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